Drug Shortage Report for TEVA-TELMISARTAN HCTZ
| Report ID | 224901 |
| Drug Identification Number | 02379252 |
| Brand name | TEVA-TELMISARTAN HCTZ |
| Common or Proper name | TEVA-TELMISARTAN/HCTZ 80/25MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE TELMISARTAN |
| Strength(s) | 25.0MG 80.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | PP30 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-10 |
| Estimated end date | 2024-07-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-04-11 | French | Compare |
| v1 | 2024-04-11 | English | Compare |
Showing 1 to 2 of 2